The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Tevadaptor® and Chemfort™ CSTDs incorporate the TOXI-GUARD® patent system that allows pressure equalization during use, preventing the escape of hazardous drug vapors into the environment during drug reconstitution and administration and prevents airborne contaminants and particles from entering the drug vial. Our manufacturing facility meets the most rigorous standards, including FDA and CE, while our Tevadaptor® and Chemfort™ product lines are approved by the world’s leading regulatory bodies.